The crude methanol extract of whole plant of Sida rhombifolia and different fractions generated from it were tested for membrane stabilizing and thrombolytic activities. In hypotonic solution-and heat-induced conditions, the chloroform soluble partitionates inhibited haemolysis of human erythrocyte by 22.11±0.14% and 64.71±0.08%, respectively as compared to 71.97±0.51% and 40.12±0.29% demonstrated by the standard acetyl salicylic acid (ASA). Moreover, the pet ether soluble materials revealed highest thrombolytic activity with clot lysis value of 19.51±0.03% as compared to 66.98±0.11% exhibited by the standard streptokinase.
Introduction
Sida rhombifolia L. (Bengali Name-Lal Berela, Family-Malvaceae) is a small erect undershrub which grows all over Bangladesh (Rahman et al., 2003) . It is used in the Indian system of medicine, Ayurveda for the treatment of fever and as diuretic (Kirtikar and Basu, 1990) , rheumatism and neurological complaints, including epilepsy (Warrier, 1994) . The roots of S. rhombifolia were used to treat diarrhoea and indigestion by Australian aborigines (Cribb and Cribb, 1982) . In Europe, the root of this species has also been used for treating tuberculosis (Mills, 1994) . The whole plant, in combination with other drugs, is prescribed as an anitdote to snake and scorpion venom (Kirtikar and Basu, 1980) . Previous phytochemical investigations of S. rhombifolia resulted in the isolation of stigmasterol, β-sitosterol, n-hexacos-11-enoic acid (Woldeyes et al., 2012) and daucosterol (Akhtaruzaman et al., 2009) .
Since this plant has important medicinal properties, the present study has been undertaken as part of our regular research program (Ferdous et. al., 2012 , Sikder et al., 2013 and we, herein, report the results of preliminary studies of membrane stabilizing and thrombolytic activities of whole plant of S. rhombifolia for the first time.
Materials and Methods

Plant materials:
The whole plant materials (roots, stems and leaves) of S. rhombifolia were collected from Tangail and a voucher specimen (DUSH-6780) for this collection has been deposited in the Salar Khan Herberium of the Department of Botany, University of Dhaka for future reference.
Extraction and fractionation:
The collected palnt parts were sun dried for several days and then oven dried for 24 hours at 40 °C to facilitate grinding. The powdered whole plant (1.75kg) of S. rhombifolia was extracted with 4.0 L methanol for 7 days and then filtered through a cotton plug followed by Whatman number 1 filter paper. The extract was then concentrated by using a rotary evaporator at reduced temperature (40-45 °C) and pressure. The concetrated aqueous methanol extract (ME) was partitionated by the modified Kupchan method (Van Wagenen et al., 1993) and the resultant patitionates i.e., pet ether (PE), carbon tetrachloride (CT), chloroform (CL) and aqueous (AQ) soluble materials were used for our current inveatigation.
Biological Investigations
i. Membrane stabilizing activity: The membrane stabilizing activity of the extractives was determined with human erythrocytes by following the method developed by Omale et al. (2008) .
ii. Thrombolytic activity: The blood was drawn from healthy volunteers without a history of oral contraceptive or anticoagulant therapy and 1.0 ml of venous blood was transferred to the previously weighed microcentrifuge tubes and was allowed to clot.
The thrombolytic activity of all extractives was evaluated by the method developed by Daginawala (2006) using streptokinase (SK) as the standard substance. The extractive (100 mg) from each plant was suspended in 10 ml of distilled water and it was kept overnight. Then the soluble supernatant was decanted and filtered through a 0.22 micron syringe filter. For clot lysis venous blood drawn from healthy volunteers was distributed in different pre-weighed sterile microcentrifuge tube (1 ml/tube) and incubated at 37° C for 45 minutes. After clot formation, the serum was completely removed without disturbing the clot and each tube containing the clot was again weighed to determine the clot weight (clot weight = weight of clot contaning tube -weight of tube alone). The ethical clearance for the experiment was obtained from the institutional ethical review committee and was performed by following the safe animal handling protocol.
To each microcentrifuge tube with the pre-weighed clot, 100 µl aqueous solution of different partitionates and crude extract was added separately. Then, 100 µl of streptokinase and 100 µl of distilled water were separately added to the positive and negative control tubes, respectively. All tubes were then incubated at 37° C for 90 minutes and observed for lysis of clot, if any. After incubation, the released fluid was removed and tubes were again weighed to observe the difference in weight after clot disruption. Difference obtained in weight taken before and after clot lysis was expressed as percentage of clot lysis as shown below: % of clot lysis, = (wt of clot after release of fluid/clot wt) × 100
Streptokinase (SK):
Commercially available lyophilized Alteplase (Streptokinase) vial (Beacon Pharmaceuticals Ltd.) of 15, 00, 000 IU, was collected and 5 ml sterile distilled water was added to it and mixed properly. This suspension was used as a stock from which 100 µl (30,000 IU) was used for in vitro thrombolysis studies.
Statistical Analysis: Three replicates of each sample were used for each assay to facilitate statistical analysis and the values are reported as mean ± SD.
Results and Discussion
At 1.0 mg/ml, different partitionates of S. rhombifolia protected the haemolysis of RBC induced by hypotonic solution and heat as compared to the standard acetyl salicylic acid. The chloroform soluble fraction inhibited 22.11±0.14% and 64.71±0.08% of haemolysis of RBC induced by hypotonic solution and heat as compared to 71.97±0.51% and 40.12±0.29% demonstrated by acetyl salicylic acid, respectively (Table 1) . As a part of discovery of cardio protective drugs from natural resources, methanol extract of S. rhombifolia was subjected to assay for thrombolytic activity and the results are presented in Table 2 . Addition of 100 µl SK, a positive control (30,000 IU), to the clots and subsequent incubation for 90 minutes at 37 °C, showed 66.98±0.11% lysis of clot. On the other hand, distilled water was treated as negative control which exhibited a negligible percentage of lysis of clot 3.14±0.31%. The mean difference of in percentage of clot lysis between positive and negative control was found to be statistically significant. In this study, pet ether soluble fraction of S. rhombifolia displayed highest thrombolytic activity (19.51±0.03%).
It is clearly evident from the above findings that S. rhombifolia has significant membrane stabilizing and thrombolytic activities. Therefore, the plant is a good candidate for further studies to isolate the bioactive principles. 
